Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.935
+0.075 (3.99%)
Nov 5, 2024, 1:22 PM EST - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $57.37 million as of November 5, 2024. Its market cap has decreased by -67.33% in one year.
Market Cap
57.37M
Enterprise Value
-261.20K
1-Year Change
-67.33%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $57.37M, a decrease of -84.32%. That is a compound annual growth rate of -43.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 55.50M | -74.20% |
| Dec 29, 2023 | 215.10M | 67.92% |
| Dec 30, 2022 | 128.10M | -69.46% |
| Dec 31, 2021 | 419.50M | 14.67% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Singular Genomics Systems | 55.68M |
| Theratechnologies | 55.46M |
| Shattuck Labs | 55.36M |
| OS Therapies | 55.34M |
| VolitionRx | 55.26M |
| Qilian International Holding Group | 54.91M |
| Actinium Pharmaceuticals | 54.83M |
| Pheton Holdings | 54.29M |